Medartis Holding AG

SIX:MED.SW

58.8 (CHF) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q4
Revenue 111.527108.755103.25194.44788.37786.3173.5767.66356.99465.66564.47960.28961.03555.43449.60626.2623.12623.12623.12620.57620.57620.57620.576
Cost of Revenue 21.96720.9223.51418.89614.43913.67912.09410.87810.2728.43210.4459.37210.9418.7448.7314.3694.1254.1254.1253.5383.5383.5383.538
Gross Profit 89.5687.83579.73775.55173.93872.63161.47656.78546.72257.23354.03450.91850.09446.6940.87521.89119.00119.00119.00117.03817.03817.03817.038
Gross Profit Ratio 0.8030.8080.7720.80.8370.8420.8360.8390.820.8720.8380.8450.8210.8420.8240.8340.8220.8220.8220.8280.8280.8280.828
Reseach & Development Expenses 22.14112.49613.4113.20712.1269.54110.5068.387.7937.0277.5196.3656.8635.8895.4752.8412.3652.3652.3652.1972.1972.1972.197
General & Administrative Expenses 017.46915.24915.35616.33613.91312.04810.78110.97213.02410.4369.84211.59110.7549.1074.9655.2275.2275.2274.1864.1864.1864.186
Selling & Marketing Expenses 049.22648.28350.17944.15642.02935.05735.84229.62932.20733.69930.46729.82725.56921.16411.6839.5759.5759.5757.6047.6047.6047.604
SG&A 71.68766.69563.53265.53660.49258.14744.94340.60145.23144.13540.30941.41836.32330.27116.64914.80214.80214.80211.79111.79111.79111.791
Other Expenses 0000000000000000-17.14-17.14-17.14-13.975-13.975-13.975-13.975
Operating Expenses 93.82879.19176.94278.74372.61767.68855.40651.3848.39452.25851.65449.98348.28143.16935.74619.490.0270.0270.0270.0130.0130.0130.013
Operating Income -4.2688.6442.795-3.1911.3214.9436.0715.405-1.6724.9752.384.2441.8134.4785.1292.1931.5631.5631.5632.1862.1862.1862.186
Operating Income Ratio -0.0380.0790.027-0.0340.0150.0570.0830.08-0.0290.0760.0370.070.030.0810.1030.0840.0680.0680.0680.1060.1060.1060.106
Total Other Income Expenses Net 6.717-6.423-2.65-5.074-0.149-4.4951.728-2.054-4.975-2.099-1.937-2.746-0.9421.56-3.118-0.181-0.24-0.24-0.24-0.273-0.273-0.273-0.273
Income Before Tax 2.4492.2210.145-8.2651.1720.4487.7993.351-6.6472.8760.4431.4980.8716.0382.0112.0121.3221.3221.3221.9131.9131.9131.913
Income Before Tax Ratio 0.0220.020.001-0.0880.0130.0050.1060.05-0.1170.0440.0070.0250.0140.1090.0410.0770.0570.0570.0570.0930.0930.0930.093
Income Tax Expense 0.6250.1820.993-2.4951.1330.5480.904-1.502-0.8191.394-0.2221.5220.3117.6730.4911.7960.4940.4940.4940.0950.0950.0950.095
Net Income 2.5651.467-0.848-5.7870.004-0.2457.0834.885-5.8281.4810.6653.021.182-1.6352.5020.2170.8290.8290.8291.8181.8181.8181.818
Net Income Ratio 0.0230.013-0.008-0.0610-0.0030.0960.072-0.1020.0230.010.050.019-0.0290.050.0080.0360.0360.0360.0880.0880.0880.088
EPS 0.190.12-0.07-0.490-0.0210.60.41-0.490.130.0570.260.12-0.121.720.0190.0710.0710.0710.150.150.150.15
EPS Diluted 0.190.12-0.07-0.490-0.0210.60.41-0.490.130.0570.260.12-0.121.720.0190.0710.0710.0710.150.150.150.15
EBITDA 6.54319.38513.0536.2979.94413.45413.94714.3845.23811.6478.6967.9025.7987.728.5734.0073.2493.2493.2493.7783.7783.7783.778
EBITDA Ratio 0.0590.1780.1260.0670.1130.1560.190.2130.0920.1770.1350.1310.0950.1390.1730.1530.140.140.140.1840.1840.1840.184